Long-Term Side Effects of Tyrosine Kinase Inhibitors in Chronic Myeloid Leukemia

There is increasing evidence that patients whose disease is controlled by TKIs will have greater impact on their quality of life from comorbidities or drug adverse events than from the disease itself.